130 related articles for article (PubMed ID: 15336545)
1. Adrenomedullin inhibits prostate cancer cell proliferation through a cAMP-independent autocrine mechanism.
Abasolo I; Wang Z; Montuenga LM; Calvo A
Biochem Biophys Res Commun; 2004 Sep; 322(3):878-86. PubMed ID: 15336545
[TBL] [Abstract][Full Text] [Related]
2. Adrenomedullin prevents apoptosis in prostate cancer cells.
Abasolo I; Montuenga LM; Calvo A
Regul Pept; 2006 Jan; 133(1-3):115-22. PubMed ID: 16297990
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin (AM) and AM receptor type 2 expression is up-regulated in prostate carcinomas (PC), and AM stimulates in vitro growth of a PC-derived cell line by enhancing proliferation and decreasing apoptosis rates.
Mazzocchi G; Malendowicz LK; Ziolkowska A; Spinazzi R; Rebuffat P; Aragona F; Ferrazzi E; Parnigotto PP; Nussdorfer GG
Int J Oncol; 2004 Dec; 25(6):1781-7. PubMed ID: 15547717
[TBL] [Abstract][Full Text] [Related]
4. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen promoter driven gene therapy targeting DNA polymerase-alpha and topoisomerase II alpha in prostate cancer.
Lee CH; Liu M; Sie KL; Lee MS
Anticancer Res; 1996; 16(4A):1805-11. PubMed ID: 8712704
[TBL] [Abstract][Full Text] [Related]
6. Adrenomedullin increases the expression of calcitonin-like receptor and receptor activity modifying protein 2 mRNA in human microvascular endothelial cells.
Schwarz N; Renshaw D; Kapas S; Hinson JP
J Endocrinol; 2006 Aug; 190(2):505-14. PubMed ID: 16899583
[TBL] [Abstract][Full Text] [Related]
7. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
[TBL] [Abstract][Full Text] [Related]
8. Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.
Berenguer C; Boudouresque F; Dussert C; Daniel L; Muracciole X; Grino M; Rossi D; Mabrouk K; Figarella-Branger D; Martin PM; Ouafik L
Oncogene; 2008 Jan; 27(4):506-18. PubMed ID: 17637748
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models.
Qian DZ; Wei YF; Wang X; Kato Y; Cheng L; Pili R
Prostate; 2007 Aug; 67(11):1182-93. PubMed ID: 17520666
[TBL] [Abstract][Full Text] [Related]
11. Identification of differentially expressed genes during cyclic adenosine monophosphate-induced neuroendocrine differentiation in the human prostatic adenocarcinoma cell line LNCaP.
Goodin JL; Rutherford CL
Mol Carcinog; 2002 Feb; 33(2):88-98. PubMed ID: 11813301
[TBL] [Abstract][Full Text] [Related]
12. Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells1.
Scaltriti M; Santamaria A; Paciucci R; Bettuzzi S
Cancer Res; 2004 Sep; 64(17):6174-82. PubMed ID: 15342402
[TBL] [Abstract][Full Text] [Related]
13. Androgen-independent expression of adrenomedullin and peptidylglycine alpha-amidating monooxygenase in human prostatic carcinoma.
Jiménez N; Abasolo I; Jongsma J; Calvo A; Garayoa M; van der Kwast TH; van Steenbrugge GJ; Montuenga LM
Mol Carcinog; 2003 Sep; 38(1):14-24. PubMed ID: 12949839
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of the HaCaT keratinocyte cell line: modulation by adrenomedullin.
Pleguezuelos O; Kapas S
Br J Dermatol; 2006 Apr; 154(4):602-8. PubMed ID: 16536800
[TBL] [Abstract][Full Text] [Related]
15. WAVE3 is associated with invasiveness in prostate cancer cells.
Fernando HS; Sanders AJ; Kynaston HG; Jiang WG
Urol Oncol; 2010; 28(3):320-7. PubMed ID: 19395286
[TBL] [Abstract][Full Text] [Related]
16. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
[TBL] [Abstract][Full Text] [Related]
17. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ
Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029
[TBL] [Abstract][Full Text] [Related]
18. Androgens target prohibitin to regulate proliferation of prostate cancer cells.
Gamble SC; Odontiadis M; Waxman J; Westbrook JA; Dunn MJ; Wait R; Lam EW; Bevan CL
Oncogene; 2004 Apr; 23(17):2996-3004. PubMed ID: 14968116
[TBL] [Abstract][Full Text] [Related]
19. Ribozyme-targeting of a secreted FGF-binding protein (FGF-BP) inhibits proliferation of prostate cancer cells in vitro and in vivo.
Aigner A; Renneberg H; Bojunga J; Apel J; Nelson PS; Czubayko F
Oncogene; 2002 Aug; 21(37):5733-42. PubMed ID: 12173043
[TBL] [Abstract][Full Text] [Related]
20. Blockade of AKT activation in prostate cancer cells with a small molecule inhibitor, 9-chloro-2-methylellipticinium acetate (CMEP).
Zhang M; Fang X; Liu H; Wang S; Yang D
Biochem Pharmacol; 2007 Jan; 73(1):15-24. PubMed ID: 16950208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
